Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$17.98 - $25.47 $194,058 - $274,897
10,793 Added 13.93%
88,278 $2.16 Million
Q1 2024

May 03, 2024

BUY
$17.59 - $23.59 $15,637 - $20,971
889 Added 1.16%
77,485 $1.65 Million
Q4 2023

Feb 08, 2024

BUY
$13.91 - $21.32 $98,121 - $150,391
7,054 Added 10.14%
76,596 $1.47 Million
Q3 2023

Nov 09, 2023

SELL
$15.99 - $23.22 $36,233 - $52,616
-2,266 Reduced 3.16%
69,542 $1.12 Million
Q2 2023

Aug 07, 2023

SELL
$17.56 - $23.76 $15,154 - $20,504
-863 Reduced 1.19%
71,808 $1.66 Million
Q1 2023

May 01, 2023

BUY
$15.26 - $23.75 $277,625 - $432,083
18,193 Added 33.4%
72,671 $1.69 Million
Q4 2022

Feb 07, 2023

SELL
$14.51 - $20.99 $51,002 - $73,779
-3,515 Reduced 6.06%
54,478 $790,000
Q3 2022

Oct 25, 2022

SELL
$18.21 - $27.88 $1,402 - $2,146
-77 Reduced 0.13%
57,993 $1.11 Million
Q2 2022

Aug 08, 2022

BUY
$16.45 - $25.88 $23,967 - $37,707
1,457 Added 2.57%
58,070 $1.06 Million
Q1 2022

May 06, 2022

SELL
$22.67 - $28.01 $21,853 - $27,001
-964 Reduced 1.67%
56,613 $1.43 Million
Q4 2021

Feb 08, 2022

SELL
$24.13 - $32.63 $3,933 - $5,318
-163 Reduced 0.28%
57,577 $1.59 Million
Q3 2021

Oct 28, 2021

BUY
$29.97 - $36.66 $9,560 - $11,694
319 Added 0.56%
57,740 $1.86 Million
Q2 2021

Jul 27, 2021

BUY
$25.39 - $32.61 $31,280 - $40,175
1,232 Added 2.19%
57,421 $1.76 Million
Q1 2021

May 03, 2021

SELL
$19.92 - $31.6 $83,683 - $132,751
-4,201 Reduced 6.96%
56,189 $1.71 Million
Q4 2020

Feb 04, 2021

SELL
$12.16 - $19.77 $114,340 - $185,897
-9,403 Reduced 13.47%
60,390 $1.19 Million
Q3 2020

Nov 06, 2020

BUY
$11.25 - $14.75 $122,490 - $160,598
10,888 Added 18.48%
69,793 $910,000
Q2 2020

Aug 04, 2020

SELL
$10.69 - $16.49 $47,442 - $73,182
-4,438 Reduced 7.01%
58,905 $668,000
Q1 2020

Apr 27, 2020

BUY
$9.78 - $29.53 $121,858 - $367,943
12,460 Added 24.49%
63,343 $906,000
Q4 2019

Feb 03, 2020

BUY
$20.93 - $35.1 $12,704 - $21,305
607 Added 1.21%
50,883 $1.39 Million
Q3 2019

Oct 31, 2019

BUY
$22.08 - $47.08 $10,598 - $22,598
480 Added 0.96%
50,276 $1.44 Million
Q2 2019

Aug 09, 2019

BUY
$22.67 - $35.0 $1,020 - $1,575
45 Added 0.09%
49,796 $1.38 Million
Q1 2019

May 02, 2019

BUY
$26.93 - $34.7 $22,298 - $28,731
828 Added 1.69%
49,751 $1.65 Million
Q4 2018

Feb 11, 2019

BUY
$27.23 - $45.56 $117,089 - $195,908
4,300 Added 9.64%
48,923 $1.42 Million
Q3 2018

Oct 22, 2018

SELL
$37.57 - $50.34 $18,634 - $24,968
-496 Reduced 1.1%
44,623 $2.05 Million
Q2 2018

Jul 23, 2018

SELL
$27.75 - $40.17 $31,163 - $45,110
-1,123 Reduced 2.43%
45,119 $1.69 Million
Q1 2018

Apr 20, 2018

SELL
$28.83 - $41.01 $16,202 - $23,047
-562 Reduced 1.2%
46,242 $1.37 Million
Q4 2017

Jan 23, 2018

SELL
$28.45 - $37.14 $89,873 - $117,325
-3,159 Reduced 6.32%
46,804 $1.61 Million
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $1.2 Million - $1.81 Million
49,963
49,963 $1.81 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.09B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.